Pyrrolidine → 3-[1-(6-Ethoxy-2-morpholino-7-pyrrolidinylcarbonylmethoxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxoquinazoline
Reaction equation
[C:1]([CH2:4][O:5][C:6]1[CH:15]=[C:14]2[C:9]([C:10]([N:22]3[CH2:27][CH2:26][CH:25]([N:28]4[C:37](=[O:38])[C:36]5[C:31](=[CH:32][CH:33]=[C:34]([CH3:39])[CH:35]=5)[N:30]([CH3:40])[C:29]4=[O:41])[CH2:24][CH2:23]3)=[N:11][C:12]([N:16]3[CH2:21][CH2:20][O:19][CH2:18][CH2:17]3)=[N:13]2)=[CH:8][C:7]=1[O:42][CH2:43][CH3:44])(O)=[O:2].[NH:45]1[CH2:49][CH2:48][CH2:47][CH2:46]1>>[CH2:43]([O:42][C:7]1[CH:8]=[C:9]2[C:14](=[CH:15][C:6]=1[O:5][CH2:4][C:1]([N:45]1[CH2:49][CH2:48][CH2:47][CH2:46]1)=[O:2])[N:13]=[C:12]([N:16]1[CH2:21][CH2:20][O:19][CH2:18][CH2:17]1)[N:11]=[C:10]2[N:22]1[CH2:27][CH2:26][CH:25]([N:28]2[C:37](=[O:38])[C:36]3[C:31](=[CH:32][CH:33]=[C:34]([CH3:39])[CH:35]=3)[N:30]([CH3:40])[C:29]2=[O:41])[CH2:24][CH2:23]1)[CH3:44]Participants
3
Procedure
The same procedure as in Example 57 was repeated, using 300 mg (0.50 mmol) of Compound 56 obtained in Example 56, except that pyrrolidine was used in place of isopropylamine, to give 48 mg (yield: 15%) of Compound 58 as white crystals.
Sources & evidence
- ORD record
- ord-1ed6f585f205431d8a1af9728fe374ef
- Source dataset
- uspto-grants-1999_09
- Patent number
- US05948784
Reaction notes
Loading…